Table 2 Influencing factors of recurrent revision and functional outcome
Group (n) | Recurrent revision N (%) | P value | Final DASH score M ± SD/M (range) | P value |
|---|---|---|---|---|
Total (28) | 3 (10.7%) | 18.14 ± 5.39 | ||
Gender | ||||
Male (16) | 2 (12.5%) | 20.80 ± 8.38 | ||
Female (12) | 1 (8.3%) | 1.000 | 14.62 ± 6.07 | 0.579 |
Age | ||||
< 40 years (16) | 3 (18.8%) | 25.21 ± 8.51 | ||
≥ 40 years (12) | 0 (0.0%) | 0.238 | 8.71 ± 4.53 | 0.101 |
Infection duration | ||||
< 12 months (14) | 0 (0.0%) | 18.27 ± 7.21 | ||
≥ 12 months (14) | 3 (21.4%) | 0.222 | 17.62 ± 8.29 | 0.925 |
Comorbidity | ||||
Yes (6) | 1 (16.7%) | 69.28 ± 5.63 | ||
None (22) | 2 (9.1%) | 0.530 | 4.20 ± 1.50 | 0.000 |
Aetiology | ||||
Post-traumatic (12) | 0 (0.0%) | 24.23 ± 9.41 | ||
Haematogenous (16) | 3 (18.8%) | 0.238 | 13.58 ± 6.29 | 0.337 |
Classification | ||||
Type I (8) | 3 (33.3%) | 1.1 (0-55.6) | ||
Type III (11) | 0 (0.0%) | 8.05 (0-77.8) | ||
Type IV (9) | 0 (0.0%) | 0.015 | 5 (0-86.7) | 0.359 |
Bone graft | ||||
Stage graft (13) | 0 (0.0%) | 15.70 ± 7.56 | ||
None (15) | 3 (20.0%) | 0.226 | 20.27 ± 7.83 | 0.681 |
Post-debridement fixation | ||||
Antibiotic cement-coated plate (17) | 0 (0.0%) | 0.050 | 22.34 ± 7.77 | |
None (11) | 3 (27.3%) | 11.67 ± 6.59 | 0.343 | |